Our Executive

Elizabeth de Somer – Chief Executive Officer

Elizabeth de Somer - Chief Executive Officer

Liz de Somer was appointed as the first female CEO of Medicines Australia in 2018. She is a dedicated advocate and policy expert for the pharmaceutical sector and is well known for her contributions to national policy development.

Liz has a lifetime of experience in health care and pharmaceutical health policy with a core focus on improving the lives of patients.

Liz began her career in nursing and spent over 10 years as an Intensive Care nurse in the front line of critical care in London and Australia. A chance role supporting a clinical research trial ignited a passion for drug development, leading Liz to a Master of Medical Science (UNSW) in 2007.

Liz has worked across drug development, clinical research, regulatory affairs, and market access in the pharmaceutical industry. Liz contributes her clinical and industry expertise to a number of expert committees providing advice to Government and brings decades of experience to her role, having worked at the frontline of the medical field including as an intensive care nurse, clinical trials coordinator and clinical research associate.

Liz provides occasional lectures on drug development, regulation of medicines, quality use of medicines and the policy environment affecting access to medicines in Australia.

Tony Marks – Head of Operations and Company Secretary

Tony Marks - Head of Operations and Company Secretary

Tony is an experienced corporate executive with sophisticated financial, corporate strategy and leadership skills. He has initiated and led major organisation-wide strategic reforms, combining financial, human capital and technology reforms in commercial, government and not for profit organisations, including science, research and regulatory based. He has a passion for supporting organisations with technical/expert workforces undergo cultural change and strategic transformation in complex and uncertain operating environments, delivering the full suite of financial and corporate services to CEOs, Boards and members.

Tony holds a Bachelor of Commerce (Accounting), Graduate Diploma in Applied Finance, and Global Executive MBA delivered through residentials in Sydney, Bangalore, Silicon Valley, Cambridge and France. He is a fellow of CPA Australia, and a member of the Australian Human Resources Institute and Australian Institute of Company Directors. He is a divisional councillor and former President and of CPA Australia’s ACT Division.

Jamie Snashall – Head of Government Relations

Jamie Snashall - Head of Government Relations

Jamie Snashall is the Head of Government Relations at Medicines Australia and has 25 years of experience in public policy and government relations. He joined Medicines Australia in October 2018 as Director, Public Affairs after time at the Australian Medical Association as Director, Public Health.

Jamie was Deputy Head of Government Relations for almost 9 years with Telstra, working across a range of business units including Telstra Health.

From 2001 to 2004, he was political and media adviser for Julia Gillard in the health and immigration portfolios and also coordinated the Opposition’s question time strategy in an election year.  In Victoria, he was senior adviser to Rob Hulls, Attorney-General and Minister for Planning in the Bracks Government.

Jamie holds a Masters’ degree in public administration from Harvard University’s Kennedy School and an Honours degree in political science from the ANU.

Anne-Maree Englund – Head of Strategic Policy Implementation

Anne-Maree Englund - Head of Strategic Policy Implementation

Anne-Maree Englund is passionate about the potential of innovative technologies to improve health outcomes. She has over 20 years’ experience in the biopharmaceutical and medical technology industries. An engineer by trade, she started her career at the medical device innovator Cochlear, with roles in manufacturing and quality management, including four years in Switzerland and Belgium.

She has been General Manager of Operations at health IT startup Humanetix, seeing the company through a successful clinical trial of their unique software. After completing a masters in public policy, she worked as Policy Manager at pharmaceutical company MSD. She is currently Head of Strategic Policy Implementation at Medicines Australia, a role which perfectly combines her interests in medical innovation and health policy.

Sophie Hibburd – Head of Ethics and Compliance

Sophie Hibburd - Head of Ethics and Compliance

Sophie Hibburd is the Head of Ethics and Compliance at Medicines Australia, where she has influenced the industry Code of Conduct since 2010. Sophie’s goal is to empower risk-based decision making that reflects an ethical culture. With a background in pharmacy, and a life-long passion for healthcare, Sophie has an unwavering commitment to ethics, integrity, and compliance.

Sophie is a member of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) ethics and business integrity Committee (IFPMA eBIC), as well as co-chair of the International Government Organisation Working Group (iGO) where she engages with counterparts globally to influence governance and ethics requirements and build unity and support cross-border relationships.

In Australia, Sophie is a keen contributor to the Australian Ethical Health Alliance (AEHA) and supports the Alliance’s work through participation in the steering committee. Sophie is committed to sharing her knowledge on the Code of Conduct, the practical implementation of the requirements, and helping people make the right decision.